Live Coverage
Updates appear automatically as they are published.
Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?
Loading chart data...
Quick Read
-
RKLB guides Q2 revenue to between $225M and $240M, representing approximately 60% YoY growth, backed by a $2.2B backlog and fresh defense contract wins reinforcing the growth thesis.
-
Neutron's late-2026 debut timeline and margin deceleration are the critical execution tests underpinning RKLB's $47B market cap against unprofitable operations.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Rocket Lab didn't make the cut. Grab the names FREE today.
Live Updates
What to Watch in Rocket Lab's Q2 Earnings Tonight
Live
Rocket Lab reports second-quarter earnings after the market closes today, with management guiding for revenue between $225 million and $240 million.
Investors will be listening closely for confirmation that Neutron remains on schedule for its highly anticipated late-2026 debut following last year’s stage-1 tank testing setback.
Margins will also be something management pays close attention to, as Rocket Lab delivered a 43.0% non-GAAP gross margin in Q1, while its Q2 outlook calls for that figure to moderate to between 38-40%.
With Rocket Lab valued at roughly $50 billion despite remaining unprofitable, tonight’s report must reinforce the pillars supporting its valuation: Neutron’s development remains on track, defense contract wins continue compounding, and Space Systems margins have room to expand.
Analysts have an average price target of $111.31, implying the stock has over 30% upside today.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) reports Q2 FY2026 earnings today, August 10, at 4:05 PM ET, with management’s earnings call at 5:00 PM ET. Shares sit near $81 after climbing 15% in the past week.
Momentum Meets Execution Risk
Last quarter set a high bar. Rocket Lab posted $200.3 million in revenue, up 63.5% YoY, and beat EPS estimates by 11.05% at -$0.07. Shares jumped 34.22% following the earnings report.
Since then, the story has broadened. RKLB captured a $266 million Space Force suborbital contract in July and a $397 million “Flatellites” award in early August. Backlog stood at $2.2 billion, up 108% YoY. Liquidity exceeds $2 billion, with $450.4 million raised via ATM in Q1 fueling M&A and Neutron scaling.
Consensus Estimates
| Metric | Q2’26 Guide Midpoint | YoY Change | FY2025 Actual | FY2026 Trajectory |
|---|---|---|---|---|
| Revenue | $232.5M | ~+60% | $601.8M | Scaling on Neutron + acquisitions |
| EPS (Est.) | -$0.08 | Improving | -$0.37 | Profitability targeted 2027 |
| Non-GAAP Gross Margin | 38%-40% | +400-600 bps | ~mid-30s | Deceleration from Q1’s 43% |
The setup implies growth stays torrid, but margins cool as SDA Tranche 3 volume and Mynaric mix in. The company’s adjusted EBITDA loss is expected to widen to $20M-$26M from Q1’s $11.8 million.
What I’m Watching: Neutron, Margins, and the Defense Ramp
Tonight, I’ll be watching four things in Rocket Lab’s earning. First, Neutron milestones. CEO Peter Beck flagged that “the continued placing of items on test stands” is the clearest signal of progress.
Second, margin mix. Non-GAAP gross margin beat guidance by 200 bps in Q1. Guidance calls for a step-down, but investors will be interested to see how much of this is driven by the SDA Tranche 3 dilution versus Mynaric’s lower initial margin profile?
Third, contract velocity. Q1 delivered 31 new Electron/HASTE contracts plus 5 Neutron missions. The $397M Flatellites win should show up in bookings.
Fourth, dilution. Beck stated “Of all of the things that I sit awake at night worrying about, Neutron demand is just not one of them.” Still, analysts will be interested to see future dilution expectations, with weighted shares outstanding currently at 629 million and SBC of $19M-$21M. Prediction markets assign a 67.5% probability to a Q2 beat.
Earnings History
| Quarter | EPS Surprise | Day-of Move | 1-Week Move | 30-Day Move |
|---|---|---|---|---|
| Q1 2026 | +11.05% | +34.22% | +18.3% | -0.4% |
| Q4 2025 | +8.16% | -4.89% | +1.46% | -7.06% |
| Q3 2025 | +71.29% | -1.27% | -16.51% | +20% |
| Q2 2025 | -69.71% | +1.09% | -0.94% | +3.31% |
On average, shares moved 5.4% seven days after earnings across recent quarters.
Contact [email protected] for any questions or corrections.
Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 250 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.
Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.
He specializes in breaking down complex companies into clear, actionable insights for everyday investors, with a focus on fundamentals-driven research.
His work has also been featured on platforms including Seeking Alpha and Sure Dividend.
Outside of work, Thomas enjoys weight lifting and soccer.
© 24/7 Wall St.
Top Gaining Stocks
Top Losing Stocks